Information  X 
Enter a valid email address

Valereum Blockchain (VLRM)


Thursday 01 July, 2021

Valereum Blockchain

Completion of £1 million Placing at 70p and TVR

RNS Number : 8090D
Valereum Blockchain PLC
01 July 2021

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")





1 July 2021

Valereum Blockchain Plc


Completion of £1 million Placing at 70p and Total Voting Rights


Valereum Blockchain Plc (AQSE: VLRM), the uniquely positioned Gibraltar based blockchain technology builder, is pleased to advise that it has completed the £1 million placing at 70 pence per share, as announced on 21 June 2021.


Total Voting Rights


The Company's total issued and voting share capital consists of 66,398,453 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company.






The website address of the Company is .


Valereum Blockchain Plc

Richard Poulden, Chairman

Tel: +44 7551 863830


AQSE Growth Market Corporate Adviser

Peterhouse Capital Limited

Guy Miller / Allie Feuerlein

Tel: +44 (0) 207 469 0930


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t